Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 115 | 0 | -1 | 99 | 26 |
| Operating Expenses | 20,220 | 15,165 | 8,223 | 7,318 | 8,886 |
| Operating Income | -20,105 | -15,165 | -8,223 | -7,219 | -8,860 |
| Interest Expense | 40 | 48 | 43 | 47 | 50 |
| Other Income | -32,237 | -54,833 | -10,863 | -2,237 | 3,971 |
| Pre-tax Income | -52,382 | -70,046 | -19,128 | -9,504 | -4,938 |
| Income Tax | 28 | 23 | 4 | 13 | 9 |
| Net Income Continuous | -52,410 | -70,069 | -19,132 | -9,517 | -4,947 |
| Net Income | $-52,410 | $-70,069 | $-19,132 | $-9,517 | $-4,947 |
| EPS Basic Total Ops | -0.63 | -1.07 | -0.72 | -0.34 | -0.18 |
| EPS Basic Continuous Ops | -0.63 | -1.07 | -0.72 | -0.34 | -0.18 |
| EPS Diluted Total Ops | -0.63 | -1.07 | -0.72 | -0.34 | -0.18 |
| EPS Diluted Continuous Ops | -0.63 | -1.07 | -0.72 | -0.34 | -0.18 |
| EBITDA(a) | $-52,144 | $-69,799 | $-18,878 | $-8,826 | $-4,230 |